GGrantIndex
← Leaderboards

Susan Heckbert

University Of Washington

$14,216,326
Attributed
$18,610,919
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200522
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$18,610,919 · 9

By mechanism

R01$17,266,019 · 6
R56$1,159,176 · 2
R21$185,724 · 1

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Risk Factors

Research focus

Risk FactorsAtrial FibrillationStrokeCardiovascular DiseasesCohortFollow-UpHeart FailurePreventionDiabetes MellitusHypertensionDementiaParticipantHeart RhythmHeart DiseasesMyocardial InfarctionHeart AtriumCohort StudiesMonitorArrhythmiaMonitoring DeviceLeftCardiovascular SystemLeft Ventricular MassCardiac

Grant awards (26)

Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk$589,365
R01 · FY2022 · HL · contact PI
Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk$586,845
R01 · FY2021 · HL · contact PI
Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk$586,845
R01 · FY2020 · HL · contact PI
Heart Rate Fragmentation: New Biomarker of Atrial Fibrillation Risk$595,865
R01 · FY2019 · HL · contact PI
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA$1,504,364
R01 · FY2018 · HL · contact PI
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA$388,990
R01 · FY2018 · HL · contact PI
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA$1,972,025
R01 · FY2017 · HL · contact PI
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment$777,434
R01 · FY2017 · HL
Epidemiology of HIV-Related Atrial Fibrillation$359,808
R56 · FY2017 · AG · contact PI
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA$2,011,739
R01 · FY2016 · HL · contact PI
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment$763,655
R01 · FY2016 · HL
Atrial fibrillation burden, vascular disease of the brain and cardiac MRI in MESA$1,520,158
R01 · FY2015 · HL · contact PI
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment$811,316
R01 · FY2015 · HL
Atrial Fibrillation in MESA and JHS$92,160
R21 · FY2015 · HL · contact PI
Cardiovascular, Pulmonary and Hematological Disease in HIV: Prevention and Treatment$799,368
R56 · FY2014 · HL
Atrial Fibrillation in MESA and JHS$93,564
R21 · FY2014 · HL · contact PI
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$438,684
R01 · FY2012 · HL
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$468,765
R01 · FY2011 · HL
Atrial Fibrillation: Incidence, Risk Factors, and Genetics$566,313
R01 · FY2010 · HL · contact PI
Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF$493,621
R01 · FY2010 · HL
Atrial Fibrillation: Incidence, Risk Factors, and Genetics$627,821
R01 · FY2009 · HL · contact PI
Atrial Fibrillation Incidence, Risk Factors and Genetics$598,495
R01 · FY2005 · HL
Atrial Fibrillation Incidence, Risk Factors and Genetics$589,677
R01 · FY2004 · HL
Atrial Fibrillation Incidence, Risk Factors and Genetics$570,267
R01 · FY2003 · HL
Atrial Fibrillation Incidence, Risk Factors and Genetics$570,437
R01 · FY2002 · HL
PHARMACOGENETICS AND RESPONSE TO THERAPY IN OLDER ADULTS$233,338
R01 · FY2000 · AG